15.60USD-4.12%Mkt Cap: 1.17B $P/E: —1d ago
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pa…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap1.17B $
Enterprise Value873.69M $
Revenue (TTM)254.90M $
Gross Profit142.61M $
Net Income (TTM)-103.27M $
Revenue/Share3.460 USD
Last Price15.60 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees850
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.40
PEG—
EV/EBITDA-5.50
EV/Revenue3.43
P/S4.57
P/B3.71
EPS (TTM)-1.40
EPS (Forward)-1.66
52W Range
10.9536% of range23.75
52W High23.75 USD
52W Low10.95 USD
Profitability
Gross Margin55.74%
Oper. Margin-83.29%
EBITDA Margin-62.33%
Profit Margin-40.36%
ROE-28.37%
ROA-14.22%
Growth
Revenue Growth-1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF13.90M $
CapEx (TTM)1.44M $
FCF Margin-19.39%
FCF Yield-4.24%
Net Debt-291.95M $
Net Debt/EBITDA1.84
Balance Sheet
Debt/Equity0.30
Current Ratio2.74
Quick Ratio2.64
Book Value/Sh4.206 USD
Cash/Share5.339 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)20.57 USD
Upside (mean)+31.9%
Target Range13.00 USD – 30.00 USD
$13.00+31.9% to mean$30.00
# Analysts7
Ownership
Shares Out.65.56M
Float57.65M
Insiders3.01%
Institutions98.22%
Short Interest
Short Ratio6.8d
Short % Float25.09%
Short % Out.14.06%
Shares Short10.51M
Short (prev mo.)10.42M
Technical
SMA 5014.65 (+6.5%)
SMA 20015.55 (+0.3%)
Beta1.62
S&P 52W Chg20.25%
Avg Vol (30d)1.32M
Avg Vol (10d)1.10M
Technical Indicators
RSI (14)48.9
MACD0.4521
MACD Signal0.6234
MACD Hist.-0.1713
BB Upper17.53 USD
BB Middle16.15 USD
BB Lower14.76 USD
BB Width17.21%
ATR (14)0.9568 USD
Vol Ratio (20d)0.93x